Blue Horseshoe Stocks: KMX Recap & More

CarMax, Inc. KMX 

First up this morning, we’re going to start off the fresh trading week by reviewing the performance of the CarMax options we signaled in Friday’s premarket report on the heels of the company’s Q2 earnings beat.

We’re constantly pounding the table on post-earning options trading, simply because we are so very often successful in our selections. Volatility is a swing trader’s best friend, and few things create it more quickly and effectively than a solid beat on earnings.

So we signaled our interest in tracking the KMX Weekly $69.50-71.50 Calls and it worked like a charm:

$69.50 Calls - Range: 1.21-4.96 – Max Gain: 310%
$70 Calls – Range: 1.10-4.40 – Max Gain: 300%
$70.50 Calls – Range: .55-3.78 – Max Gain: 587%
$71 Calls – Range: .35-3.50 – Max Gain: 900%
$71.50 Calls – Range: .30-2.41 – Max Gain: 703%



Helios and Matheson Analytics, Inc. HMNY

We just updated our readers on our coverage of HMNY last Wednesday, when we pointed out that we slated the stock for tracking on August 15th and observed a subsequent low of 2.42. By midweek the stock had already made a considerable move up, but Friday’s session brought another big pop to new highs.

HMNY traded in a daily range from 5.67 to 7.95 gaining 40%, a very respectable intraday move in and of itself. The new high marked an overall move of 229% from our observed low.

Volume was much higher than average all last week, and the stock maintain roughly half of its daily advance into a fairly strong close, so we’ll need to keep monitoring HMNY for the continued establishment of higher highs and higher lows.


Extended Watchlist:
BYOC, ACER, IZEA, RIG, ARDM, INFI, IDXG

Blue Horseshoe Stocks: APC Review & More

Versartis, Inc. VSAR

It isn’t just bullish activity that draws us to a stock. Any type of increase in volatility generally causes us to take note, and the rapid fashion in which VSAR is crashing this morning is about as volatile as it gets. The company failed to meet primary endpoints on its HGH study, and the stock fell through the floor, losing over 80% of its value thus far.

Regardless of the catalyst, whenever such a huge selloff occurs in such a hurried way, we go into bottom-watch mode, and wait for the eventual bounce. So we’ll have VSAR on our radars moving forward, watching for signs of solid support and subsequent rebound.


Anadarko Petroleum Corp. APC

The announcement of an enormous 10% share reduction via buyback program had exactly the effect we suspected it would yesterday, after we signaled a range of calls to observe in our premarket report.

Those targets were the APC 09/29 $47-48.50 Calls and each of them made a move to the upside. We also mentioned we’d be watching them beyond yesterday’s session, and sure enough the stock appears to want to gap up this morning and add to the gains we’ve already witnessed, which were as follows:

$47 Calls – Range: 1-1.60 – Max Gain: 60%
$47.50 Calls - Range: 1.29-1.40 – Max Gain: 9%
$48 Calls – Range:.62-.95 – Max Gain: 53%
$48.50 Calls – Range: .50-.83 – Max Gain: 66%
_____

Fresh Post-Earnings Options Idea:
CarMax, Inc. KMX $69.50-71.50 Calls*

*We never discuss weekly options on a Friday without going out of our way to warn our readers that trading contracts with a weekly expiration on a Friday is exceedingly risky and should only ever be attempted by expert traders!!!


Extended Watchlist:
ETRM, EBIO, S, AKTX, SBGL, CAPR, MNKD

Blue Horseshoe Stocks: PZRX Review & More

PhaseRx, Inc. PZRX

It seems like most of the big runners we’ve caught up with in recent weeks have been pharma plays of one type or another, and that trend continued yesterday. PZRX was the standout performer from our premarket watchlist, trading in a rather impressive range throughout essentially the entire session.

The stock saw an early low of .82, and surged continuously up to a high of  1.55 roughly an hour before the close. It worked out to an intraday swing of 89% and came on fantastic liquidity, with more than 43X the monthly average volume flowing through the PZRX.

The stock closed with strength in the high 1.20′s and is inching back into the 1.30′s in the premarket. The move was catalyzed by the company’s 2nd drug development candidate, PRX-ASL, for the treatment of ASLD, a rare liver disorder, has received orphan drug status by the FDA. (>>View PR)

.We’ll continue to track its activity and look for higher lows and higher highs as we head into week’s end.


Iconic Brands, Inc. ICNB

We tagged ICNB as a bottom-watch play early in the week, and have begun to see the rebound that we were looking for.

We subsequently observed a low of .0058, and yesterday with the stock reaching .008, it marked an intraweek swing of 38% Once again, we’ll be looking for the establishment of higher highs and higher lows in forthcoming sessions.



SeaDrill Ltd. SDRL

Speaking of excellent bottom calls, we’ve had an even better one in SDRL. We highlighted this one in our report last Wednesday, after which time we observed the stock at a low of .22. Yesterday it attained a .62 high, representing an upswing of 182% over the span of just a few sessions. Once more, we’ll be looking out for a more sustained recovery


Anadarko Petroleum Corp. APC

We want to put a few sets of options contracts from the APC chain on watch today after noticing the annoucement of a massive share buyback program by the company to the tune of $2.5B, effectively reducing the number of outstanding shares by 10%

The stock has tested an area of recent resistance as a result in premarket trading. We’re going to radar the APC 09/29 $47-48.50 Calls, and watch them into next week.


Extended Watchlist:
VEON, BCRX, ITUS, EGO, ESNC, ABUS, BSTI

Blue Horseshoe Stocks: CAPR Recap & More

Capricor Therapeutics, Inc. CAPR

We included CAPR in yesterday’s premarket watchlist after noticing some abnormal volume and price action in the stock during the previous session. Prior to that it had been trading sideways for more than a month.

It turns out our alert came just in the nick of time, because yesterday CAPR exploded for its largest single-session spike in years. The stock opened at 1.50 and managed to run as high as 2.65, filling a good portion of the large gap on its chart, left in May. It came out to an intraday push of 77% which came on monstrous volume of just under 80 times the monthly average.


SPDR S&P500 ETF (SPY)

We discussed tracking the SPY Weekly $249.50 & $250 Calls as conditions appeared favorable to another bullish day for the market in general. The fund made a pretty solid move during the session, and that produced some decent opportunities in our designated contracts.

The $249.50′s traded from .55 to a high of .83 (+51%), while the $250′s did slightly better with a run from .29 to .49 (+69%) just before lunch hour.


Helios and Matheson Analytics, Inc. HMNY

We last tagged HMNY on August 15th, and after a solid run, the stock went under consolidation for a few weeks. However, the downturn ended at the end of last week and the move it’s made since has been pretty impressive.

HMNY saw a low of 2.42 on Thursday, and yesterday the stock achieved a new high of 6.40. That represents a four -session upswing of 164% while volume over the same period has been significantly increased.


HTG Molecular Diagnostics, Inc. HTGM

We’re interested to track HTGM today after the company announced the issuance of two method patents on its technology. We’re seeing a moderate gap-up in the premarket, but there still appears to be the good chance for a solid upside here. The stock does have a recent history containing a huge spike to more than $12.

We’ll place it on watch, and look for it to establish a string of sessions recording higher highs and higher lows moving forward.


Extended Watchlist:
WAC, DMPI, KPTI, SPI, ARWR, ALRT, PZRX, CEI

Blue Horseshoe Stocks: DMTX Review, Options & More

Dimension Therapeutics, Inc. DMTX

We alerted on DMTX after a sizable gap-up few weeks back on the morning of August 25th. That day we would observe a low of 2.90 in the stock, and it never looked back.

Throughout the month of September the stock has mostly been stair-stepping its way up in steady fashion, but news of an unsolicited buyout offer (@5.50/share) kicked this play into a much higher gear to start things off this week, and yesterday DMTX attained a high of 5.90.

That works out to a three-week double-bag swing of 103% We wouldn’t expect to see the stock travel much higher, certainly not without confirmation or further details on a proposal, but will still keep our eyes open for further activity after a very strong session yesterday.


Fresh Options Ideas

We’ve got a pair of options possibilities  to present this morning. Yesterday’s market sentiment was exceedingly bullish, with more than 65% of NASDAQ quoted stocks trading at or above their 50-day moving averages.

Today, better than expected numbers on Housing Starts and Building Permits were reported, which could assist in keeping the momentum moving.

SPDR S&P500 ETF (SPY) – For a direct market analog, we generally turn to the SPY, having had immense success with it on several separate occasions in the past. We’re going to signal the SPY Weekly $249.50 & $250 Calls for observation as we approach midweek.
_____

The Kroger Co. KR – We’re also noticing a heck of a bottom setup on KR. A strong multiple bottom signal showing the stock at a solid support level, and a couple of gaps to the upside on the chart leaves us looking at a pair of longer-term contracts. We’re going to place the KR 11/17 $23 & $24 Calls on watch in the event of a recovery for Kroger.


Extended Watchlist:
STAF, CAPR, MRTX, NTEC, NBRV, RNVA, AGTC